Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-21-004343
Date:2021-06-16
Issuer: SAGE THERAPEUTICS, INC. (SAGE)
Original Submission Date:

Reporting Person:

STARR KEVIN P
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-16 P 17,842 a $56.05 320,659 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 this transaction was executed in multiple trades at prices ranging from $56.0447 usd to $56.9527 usd. the price reported above reflects the weighted average purchase price. the issuer hereby undertakes to provide, upon request, to the sec staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Elevate your investments